Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SARDA PROTEINS LTD. - 519242 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, 14Th August, 2023 Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations").

 The Board of Directors of the Company in their meeting held on Monday, 14th August, 2023 at the Corporate Office of the company situated at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302018 (Rajasthan) which commenced at 04:00 P.M. and concluded at 05:30 P.M. inter alia transacted the businesses enclosed herewith:
14-08-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Board Meeting Intimation for Approval The Un-Audited Financial Results Of The Company For The Quarter Ended On 30Th June, 2023.

 SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve i. the Un-audited Financial Results of the company for the quarter ended on 30th June, 2023; ii. the Limited Review Report on the Un-audited Financial Results for the quarter ended on 30th June, 2023; iii. To consider and recommend the appointment of M/s S K Agarwal and Associates, Chartered Accountants (FRN:014841C) as Statutory Auditors of the company subject to the approval of members at the ensuing Annual General Meeting; iv. the day, date, time and notice of the 32nd Annual General Meeting of the Company and matters connected therewith; and v. Board's Report of the company for the financial year 2022-23 and other matters connected therewith.
07-08-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We hereby enclose herewith the Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th June, 2023 received from M/s Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company.
06-07-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has received the enclosed register from our RTA -Link Intime India Private Limited, regarding the duplicate share certificates of the Company that have been issued. Pursuant to the SEBI Circular No. SEBI/HO/MJRSD/MIRSD _ RTAMB/P/2022/8 dated January 25, 2022, a letter of confirmation will be issued to the securities holder / claimant upon completion of necessary procedures regarding duplicate share certificates.
01-07-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Closure of Trading Window

 This is to inform you that pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (as amended) read with Company''s Code of Conduct to regulate, monitor and report trading, the Trading window for trading in the securities of the Company shall remain closed for Designated Persons of the company and their relatives from 1st July, 2023 till 48 hours after the announcement of the Financial Result for the quarter ended on 30th June 2023. The date of meeting of the Board of Directors to approve the Financial Result of the Company for the quarter ended on 30th June, 2023 will be informed in due course.
29-06-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Share Transfer Agent of the Company i.e. M/s. Link Intime India Private Limited has received information about loss of share certificates from the Shareholders. The duplicate share certificate/Letter of Confirmation will be issued only after the receipt of all necessary documents from the Shareholder.
21-06-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the extract of Audited Financial Results for the quarter and year ended on 31st March, 2023 published by the company in Business Remedies (Hindi) and in The Indian Express (English) Newspapers on 01st June, 2023.
01-06-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Non-Applicability Of Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 31St March, 2023.

 Please find attached herewith, Declaration with respect to Non-applicability of Disclosure of Related Party Transactions for the half year ended 31st March, 2023.
31-05-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Approved Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2023 Along With The Statement Of Assets And Liabilities As On 31St March 2023 And Cash Flow Statement For The Year Ended On 31St March, 2023

 In accordance with Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2023 along with the Statement of Assets and Liabilities as on 31st March, 2023 and Statement of Cash Flow for the year ended on 31st March, 2023 and Auditor''s Report issued with unmodified opinion. Further, a declaration duly signed by the Managing Director and the Chief Financial Officer of the company, pursuant to Regulation 33(3)(d) of the Listing Regulations, read with SEBI Circular CIR/CFD/CMD/56/2016 dated May 27, 2016 to the effect that Auditor''s Report has been issued with unmodified opinion on the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2023 is also enclosed herewith.
30-05-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, 30Th May, 2023 Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations")

 The Board of Directors of the Company in their meeting held on Tuesday, 30th May, 2023 at the corporate office of the company situated at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302018 (Rajasthan) which commenced at 05:00 P.M. and concluded at 06:30 P.M. inter alia transacted the businesses enclosed herewith.
30-05-2023
Next Page
Close

Let's Open Free Demat Account